Simultaneous integrated boost in locally advanced cervical cancer patients ineligible for brachytherapy: Dosimetric comparison of VMAT versus helical tomotherapy
BRT remains the standard of care for cervical cancer. For patients ineligible for BRT, SIB is dosimetrically feasible; in this exploratory planning study, HT-SIB provided better target coverage and OAR sparing than VMAT-SIB. Prospective multicenter validation is necessary before wider clinical adoption.
Authors
- Aylin Fidan Korcum (ORCID: https://orcid.org/0000-0003-0318-6122)
- Timur Koca (ORCID: https://orcid.org/0000-0002-7400-1837)
- Nina Tunçel (ORCID: https://orcid.org/0000-0002-3306-1577)
- Yılmaz Bilek
- Rahmi Atıl Aksoy (ORCID: https://orcid.org/0000-0002-5399-5430)
- İsmail Hakkı SARPÜN (ORCID: https://orcid.org/0000-0002-9788-699X)
- Muhammed İsmet Sekmen
- Durmuş Ali Çetmi (ORCID: https://orcid.org/0009-0006-0863-2354)
Institutions
- Izmir University (TR)
- Akdeniz University (TR)
Publication Details
- Journal
- Journal of Applied Clinical Medical Physics
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1002/acm2.70418
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00